HD-OPM Archive
Topics › GLP-1 drugs (semaglutide, tirzepatide)

GLP-1 drugs may curb alcohol cravings, based on anecdotes and early data

Louis Nervegna · Jun 20, 2026 · ♥ 14 reactions · 6 comments · original Facebook post
GLP-1 drugs (semaglutide, tirzepatide)Alcohol, smoking & vaping
AI summary & key facts

Louis shares a BoxLife Magazine story about a man whose alcohol cravings vanished after starting Wegovy for weight loss. The article cites many anecdotal reports plus early animal and patient analyses suggesting semaglutide dampens reward-driven alcohol seeking, but it is not FDA-approved for addiction.

Link to full article:

BoxLife MagazineWeight Loss Drugs Saved This 38-Year-Old From Alcoholism... Researchers Now Say GLP-1s Could Revolutionize Addiction TreatmentJoe Breen never expected a weight-loss drug to save him from alcoholism.boxlifemagazine.com

#glp1HD #addictionHD #alcoholismHD #semaglutideHD

Joe Breen’s struggle with severe alcoholism took an unexpected turn when his doctor prescribed the GLP-1 weight-loss drug Wegovy in April 2023, initially intended to manage his weight rather than addiction.

As Breen lost significant weight, his alcohol cravings virtually vanished, a phenomenon echoed in thousands of anecdotal reports on Reddit and TikTok.

Early animal studies and large-scale patient analyses suggest semaglutide and similar GLP-1 agonists may dampen alcohol-seeking behavior by affecting brain reward pathways.

While not yet FDA-approved for addiction, these medications could revolutionize treatment for alcohol use disorder.

Breen’s 180-pound weight loss and newfound sobriety highlight their transformative potential.

More insights into the underlying science, ongoing clinical trials, and practical considerations await in the full article.

Two images of the same man before and after weight loss.
← newer: Eight lifestyle factors linked to 87% lower mortality in 276older: Daily peanut butter improved muscle power in older adults an →